Literature DB >> 18220315

Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice.

C W S Ko1, R J Cuthbert, N M Orsi, D A Brooke, S L Perry, A F Markham, P L Coletta, M A Hull.   

Abstract

Interleukin (IL)-4 receptor (IL-4R) alpha chain-dependent signalling by IL-4 and IL-13 promotes tumour growth and metastasis in mouse models of colorectal cancer. However, the role of IL-4R alpha-dependent signalling during the early, pre-malignant stages of colorectal carcinogenesis has not been investigated. Therefore, we investigated the effect of deletion of the IL-4R alpha gene on azoxymethane-induced colorectal aberrant crypt focus (ACF) multiplicity and size in Balb/c mice. IL-4R alpha(-/-) mice developed significantly more ACFs [median 8, inter-quartile range (IQR) 4-11.5; n = 9] than wild-type (WT) animals (median 4, IQR 1-6; n = 9; p = 0.04, Mann-Whitney U-test). There were significantly higher levels of IL-4 in serum from azoxymethane- and sham-treated IL-4R alpha(-/-) mice than WT animals, but no difference in serum IL-13 levels. In the absence of functional IL-4Rs, IL-13 can also signal via the IL-13R alpha2 receptor, leading to induction of transforming growth factor (TGF) beta, which has pro-tumourigenic activity at early stages of intestinal tumourigenesis. We found that mucosal TGFbeta mRNA levels and intestinal epithelial cell TGFbeta immunoreactivity were significantly higher in IL-4R alpha(-/-) mice than in WT animals. In summary, IL-4R alpha-dependent signalling has a protective, anti-neoplastic role during the post-initiation phase of azoxymethane-induced colorectal carcinogenesis in Balb/c mice. Our data should prompt thorough investigation of the role of IL-4R alpha-dependent signalling during human colorectal carcinogenesis, particularly as antagonism of IL-4R signalling represents a therapeutic strategy for asthma and other allergic diseases. Copyright (c) 2008 Pathological Society of Great Britain and Ireland

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220315     DOI: 10.1002/path.2316

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Epithelial interleukin-4 receptor expression promotes colon tumor growth.

Authors:  Felicitas L Koller; Daniel G Hwang; E A Dozier; Barbara Fingleton
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

2.  Interleukin-4 receptor-targeted liposomal doxorubicin as a model for enhancing cellular uptake and antitumor efficacy in murine colorectal cancer.

Authors:  Chih-Yung Yang; Hong-Wen Liu; Ya-Ching Tsai; Ju-Yu Tseng; Shu-Ching Liang; Chin-Yau Chen; Wei-Nan Lian; Ming-Cheng Wei; Maggie Lu; Ruey-Hwa Lu; Chi-Hung Lin; Jeng-Kai Jiang
Journal:  Cancer Biol Ther       Date:  2015-10-05       Impact factor: 4.742

Review 3.  Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13.

Authors:  Miranda A Hallett; Katherine T Venmar; Barbara Fingleton
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

4.  Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.

Authors:  Asha Jayakumar; Alfred L M Bothwell
Journal:  Neoplasia       Date:  2017-06-24       Impact factor: 5.715

5.  IL-13Rα2 Regulates the IL-13/IFN-γ Balance during Innate Lymphoid Cell and Dendritic Cell Responses to Pox Viral Vector-Based Vaccination.

Authors:  Zheyi Li; Sreeja Roy; Charani Ranasinghe
Journal:  Vaccines (Basel)       Date:  2021-05-01

6.  Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.

Authors:  Alastair L Young; Claire R Chalmers; Gillian Hawcroft; Sarah L Perry; Darren Treanor; Giles J Toogood; Pamela F Jones; Mark A Hull
Journal:  BMC Cancer       Date:  2013-02-26       Impact factor: 4.430

7.  Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.

Authors:  Nicola Ingram; Emma L Northwood; Sarah L Perry; Gemma Marston; Helen Snowden; John C Taylor; Nigel Scott; D Timothy Bishop; P Louise Coletta; Mark A Hull
Journal:  Carcinogenesis       Date:  2013-06-19       Impact factor: 4.944

8.  Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice.

Authors:  Lei Chen; Manreetpal S Brar; Frederick C C Leung; W L Wendy Hsiao
Journal:  Oncotarget       Date:  2016-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.